Prof. Andy Porter (FRSE) announced as Antoxis new chairman

Released: Friday 30th March 2012

Antoxis is pleased to announce the appointment of Prof. Andy Porter (FRSE) as chairman. Andy brings a wealth of experience to the company from his extensive involvement in the biotechnology sector, including the founder of Haptogen which was bought out by Wyeth, and his role as an Angel investor through Grampian BioPartners which he also founded.

View all News